Cancer encompasses a diverse group of neoplasms with distinct epidemiologic, genetic, pathologic, and clinical features. Translating new insights arising from cancer research into improved prevention, diagnosis, and treatment requires multi-disciplinary, interactive groups of investigators and clinicians working in an environment that permits them to bring their unique talents to bear effectively and synergistically on different aspects of these diseases.

The BRI Cancer Research Center’s mission is to promote excellence in fundamental and translational cancer research at BWH; to foster the interdisciplinary interactions that are necessary to solve central questions pertaining to cancer pathogenesis, prevention, diagnosis, and treatment; to determine the impact of cancer and its treatment on patient quality-of-life; and to communicate these advances and insights to the larger outside community of scientists, physicians, policy makers, and the general public. In doing so, the Center helps maintain a leadership position for BWH in Cancer Research, with more than 81 PIs on grants totaling more than $68 million in direct costs for research through BWH, including funding from the National Cancer Institute and several foundations for cancer-related research.